Aerovate Therapeutics Inc AVTE:NASDAQ

Last Price$12.57NASDAQ Previous Close - Last Trade as of 4:00PM ET 12/03/21
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$12.52 (1)
Ask (Size)$25.00 (4)
Day Low / HighN/A - N/A
Volume60.3 K
 

Read more news Recent News

Aerovate Therapeutics' Q3 Loss Narrows, Operating Expenses Rise
10:09AM ET 11/15/2021 MT Newswires

Aerovate Therapeutics (AVTE) posted a Q3 loss of $0.26 per share, compared with a loss of $10.13 per share a year earlier. Three analysts polled by...

Aerovate Therapeutics Slumps After Addition to Russell 2000 Index
2:11PM ET 9/20/2021 MT Newswires

Aerovate Therapeutics (AVTE) shares slumped about 28% by Monday afternoon as the biopharmaceutical company joined the Russell 2000 Index. The index...

Aerovate Therapeutics to Join Russell 2000 Index
8:21AM ET 9/17/2021 MT Newswires

Aerovate Therapeutics (AVTE) on Friday said that it will join the Russell 2000 Index effective after the US markets close Friday. The biopharmaceutical...

Wedbush Sees Aerovate's Drug Candidate AV-101 Generating Annual Revenue of Over $1 Billion
4:03PM ET 8/24/2021 MT Newswires

Wedbush said it believes that Aerovate Therapeutics' (AVTE) drug candidate AV-101 could generate sales of over $1 billion if it receives FDA approval for...

View all Commentary and Analysis

Wall Street Breakfast: What Moved Markets
7:47AM ET 10/16/2021 Seeking Alpha

Tracking Baker Brothers Portfolio - Q2 2021 Update
12:54AM ET 10/05/2021 Seeking Alpha

Wall Street Breakfast: The Week Ahead (Podcast)
7:27AM ET 7/25/2021 Seeking Alpha

Wall Street Breakfast: The Week Ahead
7:07AM ET 7/25/2021 Seeking Alpha

Company Profile

Business Description
Number of EmployeesN/A
Recent SEC Filing11/15/202110-Q

Company Highlights

Price Open$13.17
Previous Close$13.06
52 Week Range$11.40 - 29.43
Market Capitalization$306.8 M
Shares Outstanding24.4 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement02/21/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.66
Beta vs. S&P 500N/A
RevenueN/A
Net Profit MarginN/A
Return on Equity-26.28%

Analyst Ratings as of 07/23/2021

Buy
4
Overweight
0
Hold
0
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset